Search results
Results from the WOW.Com Content Network
Pusher syndrome is a condition observed in some people following a stroke or other condition which has left them with one side weakened due to hemiparesis. Sufferers exhibit a tendency to actively push away from the unweakened side, thus leading to a loss of postural balance. It can be a result of left or right brain damage.
Diagnosis is clinical, and can be established in any patient who develops sustained depressive symptoms after a stroke. [1] While these criteria can appear simple, diagnosis may be challenging due to the overlap between stroke-related neurological symptoms and depression, which can present with or without a typical depressed mood.
The Emmy winner urges people to pay attention to stroke symptoms and to advocate for themselves, warning, “If your face starts to fall in any way or has numbness, if your arm feels strange or ...
Cerebral infarction, also known as an ischemic stroke, is the pathologic process that results in an area of necrotic tissue in the brain (cerebral infarct). [1] In mid to high income countries, a stroke is the main reason for disability among people and the 2nd cause of death. [2]
Stroke is the 5th-leading cause of death in the U.S. and a leading cause of severe disability. On average, a person dies from stroke every 4 minutes. He was given hours to live after stroke. 17 ...
Two other cohorts represented the vaccination era from June through December 2021: Vaccinated: 14 million people. Female: 52%. Median age: 53. COVID diagnosis: 6%. Unvaccinated: 3.2 million people ...
Brain ischemia has been linked to a variety of diseases or abnormalities. Individuals with sickle cell anemia, compressed blood vessels, ventricular tachycardia, plaque buildup in the arteries, blood clots, extremely low blood pressure as a result of heart attack, and congenital heart defects have a higher predisposition to brain ischemia in comparison to the average population.
The FDA looked at data from Medicare claims of more than 5.3 million adults aged 65 or older who received a bivalent COVID-19 vaccine made by Pfizer or Moderna as a basis for the study.